Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
Identifieur interne : 000206 ( PubMed/Curation ); précédent : 000205; suivant : 000207Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
Auteurs : Joe F. Lau [États-Unis] ; Steven M. Dean [États-Unis] ; Thom W. Rooke [États-Unis] ; Jeffrey W. Olin [États-Unis]Source :
- Vascular medicine (London, England) [ 1477-0377 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Antipaludiques, Hydroxychloroquine.
- Adulte d'âge moyen, Humains, Hyperpigmentation, Mâle.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antimalarials, Hydroxychloroquine.
- chemically induced : Hyperpigmentation.
- Humans, Male, Middle Aged.
DOI: 10.1177/1358863X16650276
PubMed: 27197682
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000206
Links to Exploration step
pubmed:27197682Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serpentine supravenous hyperpigmentation due to hydroxychloroquine.</title><author><name sortKey="Lau, Joe F" sort="Lau, Joe F" uniqKey="Lau J" first="Joe F" last="Lau">Joe F. Lau</name><affiliation wicri:level="1"><nlm:affiliation>Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY, USA JLau@northwell.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY</wicri:regionArea></affiliation></author><author><name sortKey="Dean, Steven M" sort="Dean, Steven M" uniqKey="Dean S" first="Steven M" last="Dean">Steven M. Dean</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH</wicri:regionArea></affiliation></author><author><name sortKey="Rooke, Thom W" sort="Rooke, Thom W" uniqKey="Rooke T" first="Thom W" last="Rooke">Thom W. Rooke</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation></author><author><name sortKey="Olin, Jeffrey W" sort="Olin, Jeffrey W" uniqKey="Olin J" first="Jeffrey W" last="Olin">Jeffrey W. Olin</name><affiliation wicri:level="1"><nlm:affiliation>Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27197682</idno><idno type="pmid">27197682</idno><idno type="doi">10.1177/1358863X16650276</idno><idno type="wicri:Area/PubMed/Corpus">000206</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000206</idno><idno type="wicri:Area/PubMed/Curation">000206</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000206</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serpentine supravenous hyperpigmentation due to hydroxychloroquine.</title><author><name sortKey="Lau, Joe F" sort="Lau, Joe F" uniqKey="Lau J" first="Joe F" last="Lau">Joe F. Lau</name><affiliation wicri:level="1"><nlm:affiliation>Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY, USA JLau@northwell.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY</wicri:regionArea></affiliation></author><author><name sortKey="Dean, Steven M" sort="Dean, Steven M" uniqKey="Dean S" first="Steven M" last="Dean">Steven M. Dean</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH</wicri:regionArea></affiliation></author><author><name sortKey="Rooke, Thom W" sort="Rooke, Thom W" uniqKey="Rooke T" first="Thom W" last="Rooke">Thom W. Rooke</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN</wicri:regionArea></affiliation></author><author><name sortKey="Olin, Jeffrey W" sort="Olin, Jeffrey W" uniqKey="Olin J" first="Jeffrey W" last="Olin">Jeffrey W. Olin</name><affiliation wicri:level="1"><nlm:affiliation>Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY</wicri:regionArea></affiliation></author></analytic><series><title level="j">Vascular medicine (London, England)</title><idno type="eISSN">1477-0377</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (adverse effects)</term><term>Humans</term><term>Hydroxychloroquine (adverse effects)</term><term>Hyperpigmentation (chemically induced)</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antipaludiques (effets indésirables)</term><term>Humains</term><term>Hydroxychloroquine (effets indésirables)</term><term>Hyperpigmentation ()</term><term>Mâle</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimalarials</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hyperpigmentation</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antipaludiques</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Hyperpigmentation</term><term>Mâle</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27197682</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0377</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>12</Month></PubDate></JournalIssue><Title>Vascular medicine (London, England)</Title><ISOAbbreviation>Vasc Med</ISOAbbreviation></Journal><ArticleTitle>Serpentine supravenous hyperpigmentation due to hydroxychloroquine.</ArticleTitle><Pagination><MedlinePgn>558-559</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Joe F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY, USA JLau@northwell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooke</LastName><ForeName>Thom W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olin</LastName><ForeName>Jeffrey W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vasc Med</MedlineTA><NlmUniqueID>9610930</NlmUniqueID><ISSNLinking>1358-863X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017495" MajorTopicYN="N">Hyperpigmentation</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27197682</ArticleId><ArticleId IdType="pii">1358863X16650276</ArticleId><ArticleId IdType="doi">10.1177/1358863X16650276</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000206 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000206 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27197682
|texte= Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27197682" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |